Valeria Ghisetti

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Domenico Di Carlo, F. Ceccherini‐Silberstein, R. Bellagamba, 2016, The Journal of antimicrobial chemotherapy.

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in

R. Kaiser, A. Vandamme, R. Camacho, 2013 .

Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis

G. di Perri, A. Calcagno, F. Lipani, 2017, Journal of Neuroimmune Pharmacology.

Prevalence and predictors of blood-brain barrier damage in the HAART era

A. Calcagno, F. Lipani, S. Audagnotto, 2014, Journal of NeuroVirology.

A graph neural network-based model with Out-of-Distribution Robustness for enhancing Antiretroviral Therapy Outcome Prediction for HIV-1

L. Palagi, A. Vandamme, V. Guarrasi, 2023, ArXiv.

Evolution of transmitted HIV‐1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016

M. Gismondo, O. Turriziani, M. Zazzi, 2018, HIV medicine.

Epstein-Barr Virus May Contribute to Central Nervous System Involvement in HIV-positive Individuals

T. Lupia, G. di Perri, A. Calcagno, 2018, bioRxiv.

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.

A. Calcagno, A. D’Avolio, S. Nozza, 2014, Antiviral research.